Personalized medicine: Implications for research and policy

被引:0
|
作者
Steinke, Douglas [1 ]
Ashcroft, Darren [1 ]
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Ctr Pharmacoepidemiol & Drug Safety, Manchester, Lancs, England
关键词
D O I
10.1177/1355819613476276
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:65 / 66
页数:2
相关论文
共 50 条
  • [41] Residual Kidney Function: Implications in the Era of Personalized Medicine
    Shafi, Tariq
    Mullangi, Surekha
    Toth-Manikowski, Stephanie M.
    Hwang, Seungyoung
    Michels, Wieneke M.
    SEMINARS IN DIALYSIS, 2017, 30 (03) : 241 - 245
  • [42] Next generation sequencing: implications in personalized medicine and pharmacogenomics
    Rabbani, Bahareh
    Nakaoka, Hirofumi
    Akhondzadeh, Shahin
    Tekin, Mustafa
    Mahdieh, Nejat
    MOLECULAR BIOSYSTEMS, 2016, 12 (06) : 1818 - 1830
  • [43] Pharmacogenetics and Cardiovascular Disease-Implications for Personalized Medicine
    Johnson, Julie A.
    Cavallari, Larisa H.
    PHARMACOLOGICAL REVIEWS, 2013, 65 (03) : 987 - 1009
  • [44] Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation
    Wolf Rogowski
    Katherine Payne
    Petra Schnell-Inderst
    Andrea Manca
    Ursula Rochau
    Beate Jahn
    Oguzhan Alagoz
    Reiner Leidl
    Uwe Siebert
    PharmacoEconomics, 2015, 33 : 49 - 59
  • [45] Prediction of Cancer Drug Resistance and implications for Personalized Medicine
    Volm, Manfred
    Efferth, Thomas
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [46] Distal Residues and Enzyme Activity: Implications for Personalized Medicine
    Ngu, Lisa
    Winters, Jenifer N.
    Makowski, Lee
    Beuning, Penny J.
    Ondrechen, Mary Jo
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 535A - 536A
  • [47] Expanding the Foundation for Personalized Medicine: Implications and Challenges for Dentistry
    Garcia, I.
    Kuska, R.
    Somerman, M. J.
    JOURNAL OF DENTAL RESEARCH, 2013, 92 (S7) : S3 - S10
  • [48] Genetics and Pharmacogenetics of Addictions and Their Implications for Personalized Medicine.
    Li, M. D.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S18 - S19
  • [49] Personalized medicine: its implications and its impact on patents
    Schneider, Dieter
    Bublak, Wolfgang
    PHARMACEUTICAL PATENT ANALYST, 2015, 4 (06) : 415 - 419
  • [50] Concepts of 'Personalization' in Personalized Medicine: Implications for Economic Evaluation
    Rogowski, Wolf
    Payne, Katherine
    Schnell-Inderst, Petra
    Manca, Andrea
    Rochau, Ursula
    Jahn, Beate
    Alagoz, Oguzhan
    Leidl, Reiner
    Siebert, Uwe
    PHARMACOECONOMICS, 2015, 33 (01) : 49 - 59